GTOQ yields 7.02% · JNJ yields 2.13%● Live data
📍 GTOQ pulled ahead of the other in Year 1
Combined, GTOQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GTOQ + JNJ for your $10,000?
IHYF utilizes a factor-based strategy that involves a systematic process that targets securities that that Sub-adviser believes will provide higher returns than other fixed income securities based on quantifiable issuer characteristics or factors. This means that the fund may have higher allocation to value bonds, low volatility bonds and high carry bonds. The funds portfolio managers may change, add and modify these factors as they deem appropriate to minimize certain risks. The fund may also invest in US Treasurys, CDOs, distressed bonds and derivatives at certain limits. Accordingly, the funds allocation limit may be deviated due to market movement. As such, the fund emphasizes the use of derivatives, such as options, futures, forward contracts, swaps, certain mortgage-related securities and asset-backed securities, in an effort to hedge against certain investment risks such as interest rates and foreign currency exposure. IHYF is a truly actively-managed fund.
Full GTOQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.